Advertisement
Legal
Subscribe to Legal

The Lead

Actavis confirms court ruling related to NAMENDA

May 26, 2015 11:17 am | by PRNewswire | News | Comments

"While we are disappointed by the Court's decision to uphold this ruling, we intend to continue our strong efforts to convey the significant benefits of NAMENDA XR@ to physicians, patients and caregivers," said Brent Saunders, CEO and President of Actavis.

Massachusetts Court Rules in Tainted Drug Case

May 19, 2015 10:51 am | by Philip Marcelo, Associated Press | News | Comments

Thousands of defendants convicted of drug crimes after a chemist in a state lab tampered with...

J&J Settles $7.8 Million Lawsuit

May 19, 2015 10:35 am | by AP | News | Comments

Three years ago a jury found that a subsidiary, Janssen Pharmaceutical, committed Medicaid fraud...

FTC Seeks More Info From Pfizer About Hospira Acquisition

May 15, 2015 12:04 pm | by Pfizer Inc. | News | Comments

Pfizer Inc. today announced that it has received a request for additional information from the...

View Sample

FREE Email Newsletter

Continuing Story: Judge Won't Toss Out FedEx Drug Indictment

May 15, 2015 11:47 am | by Sudhin Thanawala, Associated Press | News | Comments

U.S. District Court Judge Charles Breyer said the acts alleged by prosecutors do not fall under an exemption in federal drug law for transportation companies such as FedEx.

Governor Says Nebraska Has Ordered New Death Penalty Drugs

May 15, 2015 11:39 am | by Grant Schulte, The Associated Press | News | Comments

Steps are being taken to resume executions in a state that hasn't imposed the death penalty since 1997.

Colombian Ban on Anti-Coca Herbicide is Bittersweet

May 14, 2015 11:54 am | by Jacobo Garcia, Associated Press | News | Comments

Colombian President Santos last week decided to halt fumigation in the wake of a report by a research arm of the World Health Organization classifying (anti-coca) glyphosate as a probable carcinogen.

Advertisement

Personalized Medicine Gaining Traction, Facing Challenges

May 14, 2015 11:48 am | by Tufts Center for the Study of Drug Development | News | Comments

Thirteen percent of drugs marketed in the United States today post pharmacogenomic information on the label, but developers continue to encounter compliance challenges.

FedEx Seeks Dismissal of Federal Drug Indictment

May 14, 2015 11:41 am | by The Associated Press | News | Comments

Attorneys for FedEx are set to appear in court, as they seek to dismiss a federal indictment that accuses the company of knowingly shipping illegal prescription drugs from two online pharmacies.

Moving Up the Value Chain

May 14, 2015 11:35 am | by Lance Ellisor, VP of Product Management at Mitratech | News | Comments

How pharmaceutical legal departments can create a competitive advantage for the enterprise.

ProPharma Group Acquires PROSAR

May 14, 2015 11:21 am | by ProPharma Group | News | Comments

ProPharma Group, a  compliance services company, today announced its acquisition of PROSAR, a provider of pharmacovigilance and medical information services.

Pennsylvania Senate Passes Medical Marijuana Bill

May 13, 2015 11:36 am | by Marc Levy, Associated Press | News | Comments

State senators, for a second time, have sent legislation legalizing medical marijuana to the House of Representatives, where the GOP majority has held hearings but given no certain signs of support.

Advertisement

ANI Acquires Rights to Testosterone Gel 1%

May 13, 2015 11:31 am | by ANI Pharmaceuticals | News | Comments

ANI Pharmaceuticals has acquired the approved new drug application ("NDA") for a testosterone gel 1% product previously licensed to Teva Pharmaceuticals.

Obamacare Ruling Could Impact States, But Not Lawmakers

May 13, 2015 11:26 am | by Ricardo Alonso-Zaldivar, Associated Press | News | Comments

If the Supreme Court rules the way most Republicans want in the latest health overhaul case, GOP lawmakers who now have insurance coverage under President Barack Obama's law may wind up with some explaining to do.

FDA Panel Backs Vertex Combination Pill for Cystic Fibrosis

May 13, 2015 11:23 am | by Matthew Perrone, AP Health Writer | News | Comments

Federal health advisers recommended approval for an experimental combination drug to treat cystic fibrosis, despite unresolved questions about the benefit of one of the pill's two ingredients.

FDA Fast Tracks Sucampo's Cobiprostone

May 11, 2015 10:28 am | by Sucampo Pharmaceuticals | News | Comments

The FDA has granted Fast Track Designation for cobiprostone, a locally acting chloride channel activator for the prevention of oral mucositis.

California Court Sides With Consumers in Generic Drug Fight

May 8, 2015 11:48 am | by Sudhin Thanawala, Associated Press | News | Comments

The California Supreme Court ruled that settlement agreements between pharmaceutical companies that keep cheaper, generic drugs off the market may be illegal if they include excessive cash payments.

Advertisement

FDA Questions Benefit of Cystic Fibrosis Drug From Vertex

May 8, 2015 11:39 am | by Matthew Perrone, AP Health Writer | News | Comments

The Food and Drug Administration said in an online review that the benefit was small and it is unclear if the addition of a second drug ingredient adds to the pill's effectiveness.

Synthetic Pot Leads to Nationwide Spike in Hospitalizations

May 8, 2015 11:29 am | by Dave Collins, Associated Press | News | Comments

A huge nationwide spike in hospitalizations last month was caused by a class of drugs often called synthetic marijuana, possibly illustrating the potency and dangers of the chemicals used to make them.

Mylan Launches Generic Seasonale Tablets

May 7, 2015 11:50 am | by Mylan N.V. | News | Comments

Mylan N.V. today announced the U.S. launch of Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg, which is the generic version of Teva's Seasonale Tablets.

J&J Seeks Bioethics Advice on Compassionate Use of Drugs

May 7, 2015 11:39 am | by Lauran Neergaard, AP Medical Writer | News | Comments

Now drug giant Johnson & Johnson is taking an unusual step, turning to independent bioethicists for advice.

Teva Announces Adrucil Recall

May 5, 2015 11:44 am | News | Comments

Teva announced a voluntary recall of eight lots of Adrucil (fluorouracil injection, USP) 5 g/100 mL (50 mg/mL) due to the potential presence of particulate matter.

Afghan Poppy Farmers Say New Seeds Will Boost Opium Output

May 5, 2015 11:24 am | by Mirwais Khan and Lynne O'Donnell, Associated Press | News | Comments

This year, many Afghan poppy farmers are expecting a windfall as they get ready to harvest opium from a new variety of poppy seeds said to boost yield of the resin that produces heroin.

Tainted Synthetic Marijuana Sickens Users in Connecticut

May 5, 2015 11:20 am | by The Associated Press | News | Comments

Connecticut police say they are investigating a batch of tainted synthetic marijuana that has sent about a dozen people to the hospital.

Topical Treatment CMO Continues Expansion

May 5, 2015 9:55 am | by Mike Auerbach, Editor-In-Chief | Blogs | Comments

Dow Development Laboratories in California is working to position itself as the "go-to" contract manufacturer for topical product development services.

FDA Approves Spray-On Surgical Sealant

May 1, 2015 10:46 am | by FDA | News | Comments

The FDA today approved Raplixa, the first spray-dried fibrin sealant approved by the agency. It is used to help control bleeding during surgery.

Vernalis, Tris Pharma Receive FDA Approval for Tuzistra XR

May 1, 2015 10:36 am | by Vernalis | News | Comments

Tuzistra XR is an extended-release oral suspension combination of codeine and chlorpheniramine in treating coughs and upper respiratory allergies.

House Denies VA Docs On Medical Marijuana Advice

May 1, 2015 10:13 am | by Andrew Taylor, Associated Press | News | Comments

The GOP-controlled House barely rejected a bid by supporters of medical marijuana that would have permitted veterans to receive information about the drug from their government doctors.

PhRMA Critiques 21st Century Cures Bill

April 30, 2015 12:36 pm | by Pharmaceutical Research and Manufacturers of America (PhRMA) | News | Comments

The Pharmaceutical Research and Manufacturers of America (PhRMA) today released statements in that were critical of bills in the House and Senate aimed at curbing abusive patent litigation.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading